Russia's Proposed E-Cigarette Flavor Ban Passes in Parliament

Apr.12.2023
Russia's Proposed E-Cigarette Flavor Ban Passes in Parliament
Russian State Duma passes proposal to tighten e-cigarette regulations, banning flavor additives and underage usage.

On April 11th at 14:47 Moscow time, the Russian State Duma passed a proposal modifying certain legislative regulations with over 90% of the vote. The proposal aims to tighten regulations on e-cigarettes in Russia, including a ban on adding flavorings to e-cigarettes and addressing the issue of underage use.


After the proposal is passed, what are the following steps needed for the flavor ban to take effect? What is the next procedure? When does the flavor ban transition period end? In response to these questions, Liang Jiasen, a market researcher at 2FIRSTS focused on the Russian market, has reviewed and interpreted the proposal.


An Analysis of the Legislative Process in Russia:


According to Russian law, the Federal Assembly is the representative and legislative body of the Russian Federation. The Federal Assembly is composed of two chambers: the Federal Council (upper house) and the State Duma (lower house).


In the Russian legislative process, draft laws are submitted to the State Duma. Federal laws undergo a three-reading procedure in the State Duma, where a majority of votes from members is required for passage. After passage, the State Duma delivers the law to the Federation Council for review, which will approve the law if more than half of its members vote in favor or if the council fails to review it within 14 days.


In the event that the federal commission rejects a federal law, both houses can form a conciliation committee to resolve any differences that have arisen. Subsequently, the federal law should be re-evaluated by the State Duma. If the State Duma does not agree with the decision of the federal commission, and if at least two-thirds of the total number of State Duma members vote in favor during the review, the federal law will be passed.


Finally, the law that was approved by the State Duma and the Federal Assembly must be sent to the President for signing and enactment within five days. If the President rejects the law within 14 days of receiving it, the State Duma and the Federal Assembly may reconsider the law according to the prescribed procedure. If, upon reconsideration, the federal law is not amended and receives the support of no less than a two-thirds majority of both houses of representatives, the President must sign and enact the law within seven days. The diagram of the Russian legislative process is sourced from Perspective Russia.


What is the current progress of the ban on e-cigarette flavors and what are the necessary steps for it to become effective?


On April 11th, the bill regarding the regulation of electronic cigarettes was outlined. It includes provisions to ban the addition of flavorings and address the issue of preventing minors from using e-cigarettes.


According to the legislative process in Russia, the ban on this flavor has passed through three readings in the State Duma with a majority of over 90% of the votes. It will now be sent to the Federal Council (Upper House) for review within the next 5 days. If it passes the review, it will be submitted to the Presidential Administration for the signature of the President of the Russian Federation, Vladimir Putin. Once signed, the bill will be returned to the State Duma for public notice and will officially become national law.


It is known that in the legislative history of the Russian Federation, it is extremely rare for a legislative proposal to go through all three readings in the State Duma in one day. Additionally, there is no precedent where a law was approved by over 90% of the votes in the State Duma and subsequently rejected by the Federal Council.


The current proposal in legislation states that the ban on flavor additives will take effect on September 1st, with only a six-month transition period.


Topic: Updates on the Russian Ban on Electronic Cigarette Flavors and Expert Opinions (Click on the picture below to be redirected)


Further reading:


Timeline and Background of Russian Flavor Ban Bill, Passed in Three Readings within One Day


Article 2: Ban on flavored additives for e-cigarettes in Russia will take effect on September 1st; full details of the proposal attached. Article 3: Proposal in Russia to ban flavored e-cigarettes will be discussed for the first time on April 11th.


Russia has proposed a fine of up to 500,000 rubles for those selling e-cigarettes to minors.


Russian Prime Minister Mikhail Mishustin is considering a ban on electronic cigarettes.


In One Day, Three-Reading Passed Bill: A Timeline and Background of the Russian Taste Ban.


Expert Analysis Series:


Expert interpretation 1: The Russian flavor ban applies to all e-cigarette products, and specific additive standards have yet to be disclosed.


Expert Analysis 2: Russia Sets Minimum Retail Price for E-Cigarette Products to Reduce Demand for Nicotine-Based Products.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Product | JTI Launches Ploom AURA Teal Electric Pop in South Korea, Its First Dual-Color Edition
Product | JTI Launches Ploom AURA Teal Electric Pop in South Korea, Its First Dual-Color Edition
JTI Korea launched the Ploom AURA Teal Electric Pop limited edition in South Korea on September 1, 2026, marking the first dual-color design in the Ploom AURA range. The device combines a dark green body with teal accents and is accompanied by matching Front Panel, Back Cover and Pocket Bag accessories. The standalone device is priced at KRW 29,000, with three additional device-and-accessory bundles available. The release continues JTI Korea's use of limited colorways and interchangeable accessories to expand the Ploom AURA portfolio without introducing a new hardware platform.
Sep.03
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives
Spain Cigarette Volumes Fall 5.2% in August, BAT Drops 14.5%, JTI Gains Share; France Down 8.3% on Adjusted Basis
Spain Cigarette Volumes Fall 5.2% in August, BAT Drops 14.5%, JTI Gains Share; France Down 8.3% on Adjusted Basis
Spain's cigarette volumes declined 5.2% year over year in August 2026, according to government data cited by UBS and reported by Investing.com on October 7. British American Tobacco's volumes fell 14.5%, followed by Imperial Brands at 8.8%, Philip Morris International at 6.6% and Japan Tobacco at 4.6%. JTI was the only one of the four companies to gain cigarette market share, rising six basis points to 26.7%. In France, official customs data showed an unadjusted 3.7% decline in cigarette deliveries. Adjusting for the difference in delivery days produces a decline of approximately 8.3%, consistent with the UBS figure. The bank also estimated the earnings exposure of major tobacco companies to both markets.
Market
Oct.13
China STMA Deputy Administrator Meets KT&G COO as Heated Cigarette Rules Advance
China STMA Deputy Administrator Meets KT&G COO as Heated Cigarette Rules Advance
Wang Gongcheng, deputy administrator of China’s State Tobacco Monopoly Administration, met KT&G Chief Operating Officer Lee Sang-hak in Shanghai on September 1, according to Oriental Tobacco News. The meeting comes as China seeks public comment on a draft mandatory national standard for heated cigarettes. The report did not disclose the subjects discussed or indicate whether heated tobacco products or market access were addressed.
News
Sep.02
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
French vaping company Kumulus Vape reported first-half 2026 revenue of €25.5 million, down 8.3% year over year, as its core B2B distribution business fell 11% to €21.6 million. B2C and store-network revenue rose 5.6% and 17.8%, respectively. Commercial margin increased to 26.3% from 21.7%, while net profit rose 24.1% to €0.8 million. The company attributed the profitability improvement to catalog optimization, logistics restructuring and the ramp-up of Labster, its in-house production unit for proprietary brands.
Market
Sep.17 by 2Firsts Perspectives